← Open Payments lookup

WASIQ ZAIDI: Open Payments

NPI 1710920715 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$20,868 in 125 payments from 16 companies in 2025. Trend: 2023 $34,667 · 2024 $11,413 · 2025 $20,868

Speaker / faculty: $14,895Travel & lodging: $3,325Food & beverage: $2,648
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.34$14,582
ABBVIE INC.41$5,263
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$226
Alkermes, Inc.7$161
Otsuka America Pharmaceutical, Inc.7$149
Janssen Pharmaceuticals, Inc6$113
E.R. Squibb & Sons, L.L.C.4$84
Tris Pharma Inc3$68
Axsome Therapeutics, Inc.2$46
Indivior Inc.2$43

Products named: FANAPT, VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, INVEGA SUSTENNA, Dyanavel XR.

Industry payments across TX — which companies pay providers there.